Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception
|
July 5, 2012
Women's attitudes towards monthly bleeding: results of a global population-based survey
Anne Szarewski, Ariane von Stenglin, Sarah Rybowski
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception
|
August 6, 2016
A multicentre, open-label, randomised phase III study comparing a new levonorgestrel intrauterine contraceptive system (LNG-IUS 8) with combined oral contraception in young women of reproductive age
Lynn Borgatta, Kai J Buhling, Sarah Rybowski, et al.
Obstetrics and Gynecology
|
November 19, 2013
Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial
Anita Nelson, Dan Apter, Brian Hauck, et al.
Plos One
|
September 18, 2015
The Effect of Age, Parity and Body Mass Index on the Efficacy, Safety, Placement and User Satisfaction Associated With Two Low-Dose Levonorgestrel Intrauterine Contraceptive Systems: Subgroup Analyses of Data From a Phase III Trial
Kristina Gemzell-Danielsson, Dan Apter, Brian Hauck, et al.
Fertility and Sterility
|
March 27, 2016
A 12-month multicenter, randomized study comparing the levonorgestrel intrauterine system with the etonogestrel subdermal implant
Dan Apter, Paula Briggs, Marjo Tuppurainen, et al.
Drugs - Real World Outcomes
|
September 13, 2022
Real-World Patient Characteristics, Utilization Patterns, and Outcomes of US Patients with HR+, HER2- Metastatic Breast Cancer Treated with Abemaciclib
Emily Nash Smyth, Julie Beyrer, Kimberly R Saverno, et al.
Advances in Radiation Oncology
|
February 24, 2026
Utilization and Safety of Concurrent Use of Abemaciclib and Radiation Therapy Among Patients With HR+, HER2- Metastatic Breast Cancer in the Real-World Setting
Wambui Gathirua-Mwangi, Sangmi Kim, Holly Martin, et al.
The Oncologist
|
October 17, 2024
Real-world outcomes in patients with brain metastases secondary to HR+/HER2- MBC treated with abemaciclib and local intracranial therapy
Wambui Gathirua-Mwangi, Holly Martin, Dan He, et al.
Advances in Therapy
|
March 30, 2023
Characteristics and Outcomes in Cases of US Male Patients with Metastatic Breast Cancer Receiving Abemaciclib in Routine Clinical Practice
Alistair Ring, Meghan Karuturi, Emily Nash Smyth, et al.
Drugs - Real World Outcomes
|
September 29, 2023
Real-World Analysis of Clinical and Demographic Characteristics, Treatment Patterns, and Outcomes in Predominantly Older Patients with HR+/HER2- Metastatic Breast Cancer Receiving Abemaciclib in Routine Clinical Practice
Alistair Ring, Meghan Karuturi, Emily Nash Smyth, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception
|
July 5, 2012
Women's attitudes towards monthly bleeding: results of a global population-based survey
Anne Szarewski, Ariane von Stenglin, Sarah Rybowski
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception
|
August 6, 2016
A multicentre, open-label, randomised phase III study comparing a new levonorgestrel intrauterine contraceptive system (LNG-IUS 8) with combined oral contraception in young women of reproductive age
Lynn Borgatta, Kai J Buhling, Sarah Rybowski, et al.
Obstetrics and Gynecology
|
November 19, 2013
Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial
Anita Nelson, Dan Apter, Brian Hauck, et al.
Plos One
|
September 18, 2015
The Effect of Age, Parity and Body Mass Index on the Efficacy, Safety, Placement and User Satisfaction Associated With Two Low-Dose Levonorgestrel Intrauterine Contraceptive Systems: Subgroup Analyses of Data From a Phase III Trial
Kristina Gemzell-Danielsson, Dan Apter, Brian Hauck, et al.
Fertility and Sterility
|
March 27, 2016
A 12-month multicenter, randomized study comparing the levonorgestrel intrauterine system with the etonogestrel subdermal implant
Dan Apter, Paula Briggs, Marjo Tuppurainen, et al.
Drugs - Real World Outcomes
|
September 13, 2022
Real-World Patient Characteristics, Utilization Patterns, and Outcomes of US Patients with HR+, HER2- Metastatic Breast Cancer Treated with Abemaciclib
Emily Nash Smyth, Julie Beyrer, Kimberly R Saverno, et al.
Advances in Radiation Oncology
|
February 24, 2026
Utilization and Safety of Concurrent Use of Abemaciclib and Radiation Therapy Among Patients With HR+, HER2- Metastatic Breast Cancer in the Real-World Setting
Wambui Gathirua-Mwangi, Sangmi Kim, Holly Martin, et al.
The Oncologist
|
October 17, 2024
Real-world outcomes in patients with brain metastases secondary to HR+/HER2- MBC treated with abemaciclib and local intracranial therapy
Wambui Gathirua-Mwangi, Holly Martin, Dan He, et al.
Advances in Therapy
|
March 30, 2023
Characteristics and Outcomes in Cases of US Male Patients with Metastatic Breast Cancer Receiving Abemaciclib in Routine Clinical Practice
Alistair Ring, Meghan Karuturi, Emily Nash Smyth, et al.
Drugs - Real World Outcomes
|
September 29, 2023
Real-World Analysis of Clinical and Demographic Characteristics, Treatment Patterns, and Outcomes in Predominantly Older Patients with HR+/HER2- Metastatic Breast Cancer Receiving Abemaciclib in Routine Clinical Practice
Alistair Ring, Meghan Karuturi, Emily Nash Smyth, et al.
Page
of 2